Skip to main content

No Sync between DCGI and ICMR

Many people used to hear about two Medical and Research bodies like DCGI and ICMR soon after the eruption of the pandemic virus in India. Spokespersons of two bodies gave their brief on coronavirus in India to the people everyday evening. Drugs Controller General of India (DCGI) is the head of the department in the approval of licenses of specified categories of drugs. The Indian Council of Medical Research (ICMR), the apex body in India for the formulation, coordination, and promotion of biomedical research. It seems there was no coordination between the two on some issues that create confusion for the people.


The Union Health Minister announced that the first anti-viral pill was available to fight Covid-19 but the Chief of the Medical Research Council of India has stated that there is a risk of various diseases if the pills are used. In fact, this is not the first time that different system decisions have been different in the case of Covid‌-19 drugs and vaccines. The Drug Controller General of India (DCGI) on August 20 approved the emergency use of the zygote vaccine, developed by Zydus Cadila. But that was not included in the vaccination program, which runs from January 3 for 15- to 18-year-olds people. The monoclonal antibody Itolizumab, developed by Biocon, was approved by the DCGI on July 11, 2020. ICMR chief Dr. Balaram Bhargava said itolizumab could not be included in the treatment protocol for three days. 


ICMR did not include itolyzumab in the treatment protocol due to lack of proper information but Ivermectin, hydroxychloroquine, and convalescent plasma were treated differently included in the protocol. Remdesivir and favipiravir were included in the treatment protocol without proper data. In fact, the World Health Organization (WHO) announced on November 20 that hospitalizes would no longer be able to use Remdesivir, but ICMR treatment protocol continued. Why are there these differences between the ICMR protocol and DCGI approvals? Some physicians support ICMR. This is because the pharmaceutical companies explain that the DCGI allows emergency use based on their advanced data. The ICMR examines them in-depth and decides whether or not to include them in the protocol. 

Labels:

Comments

Post a Comment

Popular posts from this blog

Photo : Savitri during her last days

Even after 4 decades of her death, people are very much interested to watched her (Savitri) biopic. Mahanati turned to be stupendous success. On eve of remembering Savitri, here we posted Savitri photo. The photo seems her last days. The man stand behind Savitri is Gemini Ganeshan who married Savitri. It seems that she suffered bad days during her last days.
Post a Comment
Read more

Jagan angry on Avanthi Srinivas on Bhimili meeting!

Avanthi Srinivas was joined in YSRCP in January this year. Avanthi joined in YSRCP seeking to contest as Bhimili Assembly segment in 2019 General Elections.
Post a Comment
Read more

TRS and BJP Friendship - MIM is silent!

Congress is the main opposition to ruling TRS in Telangana State. TRS political movements too were against to Congress in the state. Recent developments reveal that TRS is the strong political Non-NDA alliance to the BJP. TRS proves it many times during the Parliament sessions. Party stall the proceedings in Lok Sabha in the name of Muslim Reservations. TRS agitation helps BJP to avoid No-Confidence Motion. KCR raises non-Congress and Non-BJP front and met many Congress alliance parties but not NDA's. Telngana Finance Minister was not attend in any Finance Ministers meeting against to 15th Finance meeting recommendations. TRS wants for SCS to Telangana when Congress Working Committee declared it's stand on giving SCS to Andhra Pradesh. All these developments uphold the rumors of possible alliance between BJP and TRS after 2019 General Elections. As per latest political development in New Delhi, that KCR held one hour long meeting with Prime Minister Naredra Modi on variou...
Post a Comment
Read more